논문 목록
Issue Date Title Journals
2020-12 A multi-centre study of trends in hepatitis B virus-related hepatocellular carcinoma risk over time during long-term entecavir therapy JOURNAL OF VIRAL HEPATITIS
2020-12 Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion Journal of hepatocellular carcinoma
2020-12 Combined use of rosuvastatin and ezetimibe improves hepatic steatosis in patients with dyslipidemia EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-11 Effect of urea cream on sorafenib-associated hand?foot skin reaction in patients with hepatocellular carcinoma: A multicenter, randomised, double-blind controlled study EUROPEAN JOURNAL OF CANCER
2020-11 Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study KOREAN JOURNAL OF INTERNAL MEDICINE
2020-11 The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization GUT AND LIVER
2020-11 Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals Cancers
2020-11 High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis JOURNAL OF VIRAL HEPATITIS
2020-11 Association between liver fibrosis and appendicular skeletal muscle mass during antiviral therapy in chronic hepatitis B DIGESTIVE AND LIVER DISEASE
2020-11 Liver-directed combined radiotherapy as a bridge to curative surgery in locally advanced hepatocellular carcinoma beyond the Milan criteria RADIOTHERAPY AND ONCOLOGY
2020-09 Advanced Liver Fibrosis Predicts Unfavorable Long-Term Prognosis in First-Ever Ischemic Stroke or Transient Ischemic Attack CEREBROVASCULAR DISEASES
2020-09 Sarcopenia Is Independently Associated with the Degree of Liver Fibrosis in Patients with Type 2 Diabetes Mellitus GUT AND LIVER
2020-09 Entecavir and tenofovir on renal function in patients with hepatitis B virus-related hepatocellular carcinoma JOURNAL OF VIRAL HEPATITIS
2020-09 Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation Cancers
2020-07 An optimized hepatocellular carcinoma prediction model for chronic hepatitis B with well-controlled viremia LIVER INTERNATIONAL
2020-07 Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study GUT AND LIVER
2020-07 Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma Clinical and molecular hepatology
2020-07 Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2020-06 Cost-effectiveness of increased screening and treatment of chronic hepatitis C in Korea CURRENT MEDICAL RESEARCH AND OPINION
2020-06 Establishment and validation of a risk prediction model in patients with hepatocellular carcinoma treated with transarterial radioembolization EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-05 Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: A korean nationwide, multicenter, prospective, observational, cohort study NUTRIENTS
2020-05 Influence of Besifovir Dipivoxil Maleate Combined with L-Carnitine on Hepatic Steatosis in Patients with Chronic Hepatitis B JOURNAL OF KOREAN MEDICAL SCIENCE
2020-05 Efficacy and Safety of Liver-Directed Concurrent Chemoradiotherapy and Sequential Sorafenib forAdvanced Hepatocellular Carcinoma: A Prospective Phase 2 Trial INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
2020-04 A tool to measure the impact of inaction toward elimination of hepatitis C: A case study in Korea PLOS ONE
2020-04 Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk AMERICAN JOURNAL OF GASTROENTEROLOGY
2020-03 Awareness and Access to Therapy in Hepatitis C Virus Infected Patients, Key Barriers to Eliminate the Virus? GUT AND LIVER
2020-03 Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma HEPATOLOGY INTERNATIONAL
2020-03 Design and validation of risk prediction model for hepatocellular carcinoma development after sustained virological response in patients with chronic hepatitis C EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-03 Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase Clinical and Translational Gastroenterology
2020-03 An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate JOURNAL OF VIRAL HEPATITIS
2020-03 Validation of the CAMD Score in Patients With Chronic Hepatitis B Virus Infection Receiving Antiviral Therapy CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2020-02 HKR3 regulates cell cycle through the inhibition of hTERT in hepatocellular carcinoma cell lines JOURNAL OF CANCER
2020-02 Dose escalation in radiotherapy for incomplete transarterial chemoembolization of hepatocellular carcinoma STRAHLENTHERAPIE UND ONKOLOGIE
2020-01 A survey on transarterial chemoembolization refractoriness and a real-world treatment pattern for hepatocellular carcinoma in Korea Clinical and molecular hepatology
2020-01 Prevention and management of viral hepatitis in inflammatory bowel disease: a clinical practice guideline by the Korean Association for the Study of Intestinal Diseases Intestinal research
2020-01 Hepatocellular carcinoma risk steadily persists over time despite long-term antiviral therapy for hepatitis B: A multicenter study CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
2020-01 Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection Clinical and molecular hepatology
2020-01 Retrospective comparison of EASL 2018 and LI-RADS 2018 for the noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging HEPATOLOGY INTERNATIONAL
2020-01 Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study MODERN RHEUMATOLOGY
2020-01 Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2020-01 Genetically engineered mouse models for liver cancer Cancers
2019-12 Predictive validation of qualitative fibrosis staging in patients with chronic hepatitis B on antiviral therapy SCIENTIFIC REPORTS
2019-12 Transarterial Chemoembolization in Treatment-Naïve and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis DIGESTIVE DISEASES AND SCIENCES
2019-12 Risk assessment of hepatocellular carcinoma development for indeterminate hepatic nodules in patients with chronic hepatitis B Clinical and molecular hepatology
2019-12 Progression of Untreated Minimally Active Chronic HBV Infection Compared to Inactive Infection CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2019-12 Intraindividual Comparison between Gadoxetate- Enhanced Magnetic Resonance Imaging and Dynamic Computed Tomography for Characterizing Focal Hepatic Lesions: A Multicenter, Multireader Study KOREAN JOURNAL OF RADIOLOGY
2019-10 Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2019-10 Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits ULTRASONOGRAPHY
2019-10 Changes in real-life practice for hepatocellular carcinoma patients in the Republic of Korea over a 12-year period: A nationwide random sample study PLOS ONE
2019-10 Conditional Survival Estimates Improve Over Time for Patients with Hepatocellular Carcinoma: An Analysis for Nationwide Korea Cancer Registry Database CANCER RESEARCH AND TREATMENT
2019-09 Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir Clinical and molecular hepatology
2019-09 External validation of the modified PAGE-B score in Asian chronic hepatitis B patients receiving antiviral therapy LIVER INTERNATIONAL
2019-09 Postoperative recurrence of hepatocellular carcinoma: The importance of distinguishing between intrahepatic metastasis and multicentric occurrence-response CLINICAL CANCER RESEARCH
2019-09 Development and validation of a prognostic model for patients with hepatocellular carcinoma undergoing radiofrequency ablation CANCER MEDICINE
2019-09 A multicenter study of entecavir vs. tenofovir on prognosis of treatment-naive chronic hepatitis B in South Korea JOURNAL OF HEPATOLOGY
2019-08 Alpha-Fetoprotein, Des-Gamma-Carboxy Prothrombin, and Modified RECIST Response as Predictors of Survival after Transarterial Radioembolization for Hepatocellular Carcinoma JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
2019-07 Radiomics on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging for Prediction of Postoperative Early and Late Recurrence of Single Hepatocellular Carcinoma CLINICAL CANCER RESEARCH
2019-06 Staged partial hepatectomy versus transarterial chemoembolization for the treatment of spontaneous hepatocellular carcinoma rupture: a multicenter analysis in Korea ANNALS OF SURGICAL TREATMENT AND RESEARCH
2019-06 Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals Clinical and Translational Gastroenterology
2019-04 Development of a New Nomogram Including Neutrophil-to-Lymphocyte Ratio to Predict Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Cancers
2019-04 Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma BMC CANCER
2019-04 Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection PLOS ONE
2019-04 Dose escalation by intensity modulated radiotherapy in liver-directed concurrent chemoradiotherapy for locally advanced BCLC stage C hepatocellular carcinoma RADIOTHERAPY AND ONCOLOGY
2019-03 Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status GUT AND LIVER
2019-03 Multicenter Retrospective Risk Assessment of Esophageal Variceal Bleeding in Patients with Cirrhosis: An Acoustic Radiation Force Impulse Elastography-Based Prediction Model GUT AND LIVER
2019-03 Subclinical but significant liver fibrosis in patients with ANCA-associated vasculitis CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2019-03 Predictors of Discordance in the Assessment of Skeletal Muscle Mass between Computed Tomography and Bioimpedance Analysis Journal of Clinical Medicine
2019-03 Evaluation of Early Response to Treatment of Hepatocellular Carcinoma with Yttrium-90 Radioembolization Using Quantitative Computed Tomography Analysis KOREAN JOURNAL OF RADIOLOGY
2019-03 Phase I/II trial of helical IMRT-based stereotactic body radiotherapy for hepatocellular carcinoma DIGESTIVE AND LIVER DISEASE
2019-02 Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals SCIENTIFIC REPORTS
2019-02 Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma RADIOTHERAPY AND ONCOLOGY
2019-02 Liver Fibrosis, Not Steatosis, Associates with Long-Term Outcomes in Ischaemic Stroke Patients CEREBROVASCULAR DISEASES
2019-01 High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2019-01 진행성 간세포암종의 새로운 전신 치료제 The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
2019-01 Fibrosis-matched outcomes between chronic hepatitis B patients with drug-induced virological response and inactive carriers LIVER INTERNATIONAL
2018-10 HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant Lymphoma CANCER RESEARCH AND TREATMENT
2018-09 Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis CANCER CHEMOTHERAPY AND PHARMACOLOGY
2018-09 Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial BMC CANCER
2018-09 Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib LIVER INTERNATIONAL
2018-08 Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2018-08 HBsAg-negative and anti-HBc-positive in eosinophilic granulomatosis with polyangiitis: a retrospective pilot study RHEUMATOLOGY INTERNATIONAL
2018-06 Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update? HEPATOLOGY
2018-05 Daclatasvir Plus Asunaprevir for the Treatment of Patients with Hepatitis C Virus Genotype 1b Infection: Real-World Efficacy, Changes in Liver Stiffness and Fibrosis Markers, and Safety GUT AND LIVER
2018-04 Feasibility of dynamic risk prediction for hepatocellular carcinoma development in patients with chronic hepatitis B LIVER INTERNATIONAL
2018-04 Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance ALIMENTARY PHARMACOLOGY & THERAPEUTICS
2018-03 Reply to "Radiologic Evaluation of Intrahepatic Cholangiocarcinoma Perineural Invasion" AMERICAN JOURNAL OF ROENTGENOLOGY
2018-03 Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
2018-03 Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B GUT AND LIVER
2018-03 Switching from tenofovir and nucleoside analogue therapy to tenofovir monotherapy in virologically suppressed chronic hepatitis B patients with antiviral resistance JOURNAL OF MEDICAL VIROLOGY
2017-12 Validation of the PAGE-B Model in Asian Chronic Hepatitis B Patients Receiving Entecavir or Tenofovir LIVER INTERNATIONAL
2017-11 Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy GUT AND LIVER
2017-11 Baracle (R) vs Baraclude (R) for 48 weeks in patients with treatment-naive chronic hepatitis B: a comparison of efficacy and safety DRUG DESIGN DEVELOPMENT AND THERAPY
2017-11 Effects of Entecavir and Tenofovir on Renal Function in Patients with Hepatitis B Virus-Related Compensated and Decompensated Cirrhosis GUT AND LIVER